Quantcast
Last updated on April 21, 2014 at 5:04 EDT

Latest Verenium Corporation Stories

2010-11-09 07:00:00

CAMBRIDGE, Mass., Nov. 9, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that Janet Roemer, President and Chief Operating Officer, will present at the upcoming Jefferies 10th Global Clean Technology Conference. The presentation is scheduled to begin at 3:45 p.m. GMT on Tuesday, November 16, 2010 and will take place in London. More information about...

2010-11-08 07:00:00

CAMBRIDGE, Mass., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance enzyme solutions, today announced the appointment of Alexander A. Fitzpatrick as Senior Vice President and General Counsel. Fitzpatrick will report to Carlos A. Riva, Verenium's President and Chief Executive Officer. "Alex has extensive experience in the biotechnology industry, as well as specific expertise with intellectual...

2010-11-02 07:00:00

CAMBRIDGE, Mass., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that it will release 2010 third quarter financial results on Tuesday, November 9, 2010 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Tuesday, November 9 at 5:00 p.m. ET. The call may be accessed by dialing...

2010-10-26 07:00:00

CAMBRIDGE, Mass., Oct. 26 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine® PLC. In 2009 Verenium and Alfa Laval signed an agreement to jointly market enzymatic degumming of vegetable...

2010-10-20 07:00:00

CAMBRIDGE, Mass., Oct. 20 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that Purifine® PLC, the Company's novel enzyme specifically developed for the edible oil industry, has received all necessary Chinese government authorizations for sale as a processing aid in the edible oil industry. With this regulatory approval, Verenium now has the ability to sell...

2010-10-12 07:00:00

CAMBRIDGE, Mass., Oct. 12 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that it has licensed a new enzyme for use in the production of edible oil products to Bunge Oils, Inc., a part of Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG). This high-performance lipase enzyme was developed as part of a research and development agreement...

2010-09-29 07:00:00

CAMBRIDGE, Mass., Sept. 29 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that it will now market and sell DELTAZYM® GA L-E5, a high performance enzyme for the saccharification of liquefied starch in the fuel ethanol production process. The DELTAZYM® GA L-E5 enzyme has demonstrated high ethanol yields at industrial scale using...

2010-09-02 15:05:00

CAMBRIDGE, Mass., Sept. 2 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced the closing of the sale of its cellulosic biofuels business to BP Biofuels North America for $98.3 million, subject to the additional financial terms of the transaction announced on July 15, 2010. In the transaction, BP acquired the Company's facilities in Jennings, LA, including the pilot plant...

2010-08-26 15:05:00

CAMBRIDGE, Mass., Aug. 26 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced the appointment of Kevin Bracken to the position of Vice President of Manufacturing. Bracken will report to Janet Roemer, President and Chief Operating Officer of Verenium's Enzymes Business. "Kevin brings over 30 years of valuable manufacturing experience from global biotechnology...

2010-08-09 15:00:00

CAMBRIDGE, Mass., Aug. 9 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today reported financial results for the second quarter of 2010. The Company also provided a summary of recent highlights and financial guidance for 2010. "This has been a transformational quarter for Verenium. The transaction we announced with BP around the sale of our cellulosic biofuels business...